2020
DOI: 10.1016/s0016-5085(20)34437-1
|View full text |Cite
|
Sign up to set email alerts
|

306 Curative Intent Therapy for Locoregional Recurrence of Esophageal Cancer Can Prolong Survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…For managing unresectable, recurrent, or metastatic squamous cell carcinoma, preferred options differ based on HER2 expression, involving various combinations of fluoropyrimidines, oxaliplatin, cisplatin, and targeted therapy (trastuzumab). In the case of adenocarcinoma, the management options mirror those for squamous cell carcinoma but are tailored based on HER2 expression and type [19,23,24].…”
Section: Recurrence In Esophageal Carcinomamentioning
confidence: 99%
“…For managing unresectable, recurrent, or metastatic squamous cell carcinoma, preferred options differ based on HER2 expression, involving various combinations of fluoropyrimidines, oxaliplatin, cisplatin, and targeted therapy (trastuzumab). In the case of adenocarcinoma, the management options mirror those for squamous cell carcinoma but are tailored based on HER2 expression and type [19,23,24].…”
Section: Recurrence In Esophageal Carcinomamentioning
confidence: 99%